Hims offered a $49 weight loss pill, then yanked it. Now Novo Nordisk is suing.
Telehealth provider Hims & Hers is facing new scrutiny on Monday after Novo Nordisk, a Danish pharmaceutical company, filed a lawsuit against it for a compounded version of GLP-1 pills. The lawsuit alleges Hims & Hers mass-marketed unapproved compounded versions of Novo’s Wegovy and Ozempic drugs. The new lawsuit comesContinue Reading












